Efficacy of telithromycin (HMR 3647) against enterococci in a mouse peritonitis model

K. V. Singh, K. K. Zscheck, B. E. Murray

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


We used a mouse peritonitis model to evaluate the in vivo efficacy of telithromycin (HMR 3647) (TEL) and erythromycin (ERY) against four strains of Enterococcusfaecalis and three strains of Enterococcus faecium with differing susceptibilities to TEL. TEL was highly active in vivo against Ery-susceptible (Erys) and -intermediate (Ery1) strains (MIC of TEL = 0.015 to 0.062 μg/ml) and showed less efficacy against Ery-resistant (Ery1) isolates (MIC of TEL = 4 to 16 μg/ml), although this was overcome in part by a second subcutaneous dose. Quinupristin-dalfopristin was also noted to have less efficacy against Eryr versus Erys or Ery1 E. faecium strains, but this difference was reduced by intravenous administration. In conclusion, TEL was more potent in vivo against enterococci than was ERY; its activity was lowered by the presence of erm(B)-mediated Eryr.

Original languageEnglish (US)
Pages (from-to)3434-3437
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Issue number12
StatePublished - 2000

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases


Dive into the research topics of 'Efficacy of telithromycin (HMR 3647) against enterococci in a mouse peritonitis model'. Together they form a unique fingerprint.

Cite this